Imperva (IMPV) Tops Q3 EPS by 19c

Go back to Imperva (IMPV) Tops Q3 EPS by 19c

Piper Jaffray Upgrades Imperva (IMPV) to Overweight

October 31, 2014 7:23 AM EDT

Piper Jaffray upgraded Imperva (NYSE: IMPV) from Neutral to Overweight with a price target of $44.00 (from $29.00).

Analyst Andrew Nowinski commented, "We are upgrading shares of IMPV to Overweight and raising our price target to $44 (prev $29) based on our belief that the security market is... More